Report Categories
View AllRecent Articles
View All
OACC Oaktree highlights ongoing life sciences deSPAC target evaluation efforts in latest quarterly earnings update
ACONW Aclarion WT investors await full quarterly earnings filings to evaluate core operational performance trends
KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today